IMCI Pharmaceuticals
Making Medical Cannabis: Safe, Reliable and Patient-focused
StartupIMCI Pharmaceuticals is a Gan Yavne-based startup in the Health Tech & Life Sciences sector, established in 2018. Making Medical Cannabis: Safe, Reliable and Patient-focused. IMCI Pharmaceuticals was founded by Alon Hershkovitz and Avi Yakobovich. The company has 1-10 employees. Core technologies: Biologicals, Herbals.
The company follows a B2B2C/B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B2C, B2B
- Employees1-10
- HQGan Yavne
- DistrictCenter District
- Last RoundUndisclosed
Alon HershkovitzCo-founder & CEO Israel
Avi YakobovichCo-founder & CEO South Africa
4 articles covered by sources including nocamels.com,
www.pharmatechoutlook.com,
www.haaretz.com,
www.startus-insights.com.
What does IMCI Pharmaceuticals do?
IMCI is a pharmaceutical company that develops innovative pharma-grade and formulated cannabis-based medications to treat chronic indications with a global reach. IMCI has developed a precise and effective dose together with an easy-to-use administration, suitable for any patient population at any time and place via its iCann medicinal cannabis platform.
Who founded IMCI Pharmaceuticals?
IMCI Pharmaceuticals was founded in 2018 by Alon Hershkovitz (Co-founder & CEO Israel), Avi Yakobovich (Co-founder & CEO South Africa).
What sector is IMCI Pharmaceuticals in?
IMCI Pharmaceuticals operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, Drugs Discovery & Development, with core technologies in Biologicals, Herbals. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is IMCI Pharmaceuticals located?
IMCI Pharmaceuticals is based in Gan Yavne, Israel, Center District. The company also has offices abroad.